MELK and cancer: Significantly, 23 of the published MELK studies report efficacy of MELK-targeted RNAi in cancer cell lines and/or xenograft tumor models, thereby directly implicating MELK function in cancer cell proliferation or tumorigenic potential (see column 4 in Table 1).